PRECIGEN, INC.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the and
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| (Amounts in thousands) | 2026 | 2025 |
| Cash flows from operating activities | ||
| Net loss | $(7,929) | $(54,153) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 1,099 | 629 |
| Change in fair value of warrant liabilities | — | 32,481 |
| Amortization of discounts on investments, net | (369) | (706) |
| Stock-based compensation expense | 3,006 | 2,677 |
| Shares issued as payment for services | 526 | 527 |
| Accretion of debt discount and amortization of deferred financing costs | 345 | — |
| Changes in operating assets and liabilities: | ||
| Receivables: | ||
| Trade | (22,487) | 175 |
| Other | 144 | (76) |
| Inventory | (4,879) | — |
| Prepaid expenses | (562) | 46 |
| Other assets | 126 | (56) |
| Accounts payable | (9,513) | (117) |
| Accrued compensation and benefits | (2,272) | 1,204 |
| Other accrued liabilities | 1,624 | 1,277 |
| Deferred revenue | (107) | (138) |
| Lease liabilities | (75) | (95) |
| Indemnification accruals | (2,476) | — |
| Other long-term liabilities | (28) | — |
| Net cash used in operating activities | (43,827) | (16,325) |
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| (Amounts in thousands) | 2026 | 2025 |
| Cash flows from investing activities | ||
| Purchases of investments | $(33,874) | $(10,408) |
| Sales and maturities of investments | 55,099 | 4,573 |
| Purchases of property, plant and equipment | (258) | (622) |
| Net cash provided by (used in) investing activities | 20,967 | (6,457) |
| Cash flows from financing activities | ||
| Payment of issuance cost related to 2024 public offering of shares | — | (355) |
| Payments to taxing authorities in connection with shares directly withheld from employees | (146) | (474) |
| Proceeds from stock option exercises | 255 | 150 |
| Net cash provided by (used in) financing activities | 109 | (679) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (3) | 2 |
| Net decrease in cash, cash equivalents, and restricted cash | (22,754) | (23,459) |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 30,234 | 29,517 |
| End of period | $7,480 | $6,058 |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the period for interest | $2,563 | $— |
| Significant noncash activities | ||
| Accrued compensation paid in equity | $3,371 | $— |
| Purchases of property and equipment included in accounts payable and other accrued liabilities | $198 | $866 |
| Issuance costs included in accounts payable and other accrued liabilities | $— | $537 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.